Navigation Links
China Cord Blood Corporation to Announce Third Quarter Fiscal 2011 Financial Results
Date:2/22/2011

HONG KONG, Feb. 22, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company") today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2011 on Monday, February 28, 2011, after market close in the US.  

The Company will hold a teleconference at 8:00 p.m. ET on Monday, February 28, 2011 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the following link: http://investor.chinacordbloodcorp.com/playerlink.zhtml?c=206671&s=wm&e=3696924. A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 40003001.

Supplemental financial information referenced in the conference call and the text of the third quarter press release will be available at http://www.chinacordbloodcorp.com, in the section titled Investor Center/Press Release, after 4:30 p.m. ET on the day of the conference call.

Please dial in ten minutes prior to the conference to ensure proper connection and be prepared to provide your name and company to the operator.

About China Cord Blood CorporationChina Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services.  For more information, please visit our website at http://www.chinacordbloodcorp.com.  For more information, please contact:China Cord Blood CorporationMs. Joeling LawTel:   +852-3605-8180Email: ir@chinacordbloodcorp.comICR, LLCIn New York: Ashley M. AmmonTel: +1-646-277-1227In Beijing: Wen Lei ZhengTel: +86-10-6583-7510
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics to Report Fiscal Year 2011 Third Quarter Financial Results on February 9
2. China-Biotics, Inc. Provides Preliminary FY2011Third Quarter Revenue
3. Reportlinker Adds Industrial Biotechnology China News 1011
4. Reportlinker Adds Financial Health of Biotechnology and Drugs Industry in India and China
5. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011
6. China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011
7. China Cord Blood Corporation Announces Completion of Warrant Exchange
8. China-Biotics Announces Redemption of $25 million in Senior Convertible Notes
9. China Cord Blood Corporation Announces Participation at the 29th Annual J.P. Morgan Healthcare Conference
10. PRA International Expert to Speak at China Drug Safety Summit
11. Tianyins Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):